Benefits of Phosphocreatine use during Tetralogy of Fallot repair in childre
Phase 3
- Conditions
- Health Condition 1: null- Children with Tetralogy of Fallot aged 6 months to 14 years undergoing intracardiac repair
- Registration Number
- CTRI/2018/01/011594
- Lead Sponsor
- GKeerthi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
all cases undergoing intracardiac repair for TOF
Exclusion Criteria
1. Emergency cases
2. TOF with Absent pulmonary valve
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method